Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,585,456
+$21,221,488 QoQ
Shares Held
371,374
+44.8% QoQ
Ownership
0.447%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#40
of 275 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. KYMR ranks #40 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in KYMR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,585,456 | 371,374 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,363,968 | 256,501 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,661,044 | 265,532 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,336,585 | 429,975 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,945,873 | 159,163 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,040,359 | 147,620 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,990,083 | 173,753 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,780,756 | 270,035 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,415,202 | 348,918 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,135,389 | 127,746 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,375,079 | 132,564 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,158,622 | 227,239 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,306,118 | 187,304 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,185,630 | 242,512 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,971,413 | 119,047 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,816,406 | 129,371 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,834,513 | 143,957 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,383,631 | 56,324 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $445,826 | 7,022 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $414,441 | 10,665 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||